Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,716 total articles
Ambarella (AMBA) is positioned to benefit from accelerating demand for on-device perception in industrial robotics after recent product launches (CV7) and trade-show exposure. The stock is technically cheap relative to recent momentum, and a mid-term swing trade captures upside from design wins and expanding edge-AI revenue while capping downside w…
Short-term headlines about memory efficiency (TurboQuant) have pressured Micron shares, but the company’s cash flow, tight HBM/SRAM supply for AI accelerators, and a still-reasonable valuation argue for a tactical long. This trade plan targets a move back toward the 52-week highs as markets reprice durable demand, with a clear stop to limit downsid…
Netflix's recent price increases, accelerating ad revenue, and a cleaner balance sheet after walking away from a large M&A bid create a high-probability asymmetric trade into the April 16 earnings report. Valuation is busy but not extreme for a company with $9.46B in free cash flow and an EV/EBITDA of 10.8. Entry at $97.66, stop $85, target $130 ov…
The iShares MSCI South Korea ETF (EWY) is a leveraged way to own Korea's AI-driven memory cycle and corporate reform story. If the Iran war ends and energy-driven risk premia roll off, EWY should re-rate from cyclical discount to growth multiple. We lay out an actionable long trade with entry, stop, targets and a balanced view of catalysts and risk…
UnitedHealth looks like a classic quiet turnaround: core insurance cash flows steady, Optum services margins stabilizing, and tailwinds from Medicare Advantage enrollment and value-based care. This is a tactical long with defined risk management—entry $560.00, stop $520.00, target $640.00—intended for a long-term horizon (180 trading days).
Silgan is a cash-generative packaging platform trading at ~14.6x earnings and EV/EBITDA of 7.7. With roughly $423M of annual free cash flow and current net debt near $3.8B, the company has a clear runway to materially reduce leverage. This trade idea buys the dip and runs the position over the next 180 trading days with a $36.15 stop and $48 target…
Dell combines a durable AI/data-center revenue runway and strong free cash flow with a valuation that still looks reasonable for the current cycle. Buy on a tactical entry near $171 with a $195 target and a $156 stop. Time horizon: long term (180 trading days).
TD SYNNEX looks positioned to reaccelerate revenue quality and margin expansion as Hyve automation deployments move from pilot to scale. I recommend a swing-to-position trade: enter at $120.00, stop at $105.00, target $150.00. Catalyst cadence and improving services mix support upside; execution and macro are the main risks.
Hut 8 reported a headline $248M loss that cleared out expectations, but investors are betting on asset value recovery, operational leverage and potential upside if Bitcoin miners re-rate. This trade idea lays out an actionable long with entry, stop and target, catalysts to watch, and a frank risk framework.
John B. Sanfilippo & Son (JBSS) is a family-run nut processor trading below $1.0 billion market cap, generating solid free cash flow and mid-teens returns on equity. With EPS up sharply in the latest fiscal quarter, conservative balance sheet metrics, and a share base under 12 million, JBSS is a candidate for a measured long trade to capture a mult…
Intel has stopped being the perennial underdog. Recent operational wins - most notably a $14.2B buyback of the minority stake in Ireland's Fab 34 - combined with stronger MLPerf benchmarking activity and improving technicals create a tradeable long. I recommend buying at $48.01, targeting $58.00 over 180 trading days and placing a stop at $43.00. S…
Kura Oncology's approval and NCCN listing for KOMZIFTI (ziftomenib) in relapsed/refractory NPM1-mutant AML shifts the company from pure R&D story to a commercial-stage asset. With a market cap near $735M and enterprise value ~ $597M, early commercial traction, reimbursement wins and label expansion represent asymmetric upside versus a defined downs…
Booking Holdings completed a 25-for-1 forward split on 04/02/2026 that should amplify retail demand and liquidity. Fundamentals remain solid — high free cash flow, mid-20s P/E, and 2025 revenue and EPS growth — making a disciplined long the preferred trade over the next 45 trading days. Risk is real: macro travel shocks, TSA disruptions, and moment…
Orla Mining has pulled back from recent highs but fundamentals and the macro gold picture argue for a constructive stance. Recent quarterly beats, steady production, a newly instituted quarterly dividend, and exploration upside make ORLA a compelling long trade over the next 180 trading days. I lay out an entry, stop, targets, catalysts and balance…
MP Materials is trading well below its 52-week high despite secured government-linked demand and a clear path to vertical integration. The pullback offers an asymmetric risk-reward for disciplined longs who size positions and use a strict stop. This trade idea lays out entry, stop, target, catalysts and risks for a long-term (180 trading days) play…
Rakuten Group's ADR is trading at $4.84 with a market cap roughly $10.5B. The mobile business keeps headline risk high, but Internet Services and FinTech show structural growth and strategic partnerships that could unlock value. Technicals and short interest suggest a volatile base — a measured long position with a clear stop and a 180-trading-day …
Atlantic Union Bankshares looks positioned to sustain healthy earnings growth as loan volumes recover and net interest margins stay elevated. With a focused regional footprint, manageable balance sheet composition and improving fee income, the risk/reward for a mid-term long appears attractive. This trade idea lays out a specific entry, stop and ta…
<p>CoreWeave remains my preferred pure-play bet on GPU infrastructure despite clear execution and balance-sheet risks. The company sits on a multiyear demand wave from generative AI, a massive contracted backlog, and accelerating revenue guidance. That combination justifies a high-risk, high-reward long position with disciplined sizing.</p>
Lufthansa is a buy on a repeatable MRO revenue cycle, improving free cash flow and a corporate focus on capital returns. We favor a mid-term trade that captures expanding maintenance margins, continued demand for spares and heavy checks, and potential buyback/tender activity as cash generation normalizes.
Hess Midstream (HESM) offers a tactical long opportunity after a recent geopolitical re-pricing. With the market refocusing on Middle East supply risk, near-term concerns about Bakken takeaway capacity and volume declines have receded. HESM's steady free cash flow ($728M), high yield (~7.6%), and reasonable EV/EBITDA (~7.1x) give asymmetric upside …
AI inference workloads are forcing a rethink of storage architecture: lots of cheap, dense capacity at scale. Western Digital is sitting at the intersection of that shortage and supply-constrained pricing. The trade: buy WDC at $299, protect at $250, target $350 over a 180-trading-day horizon, with partial profit-taking earlier.
Microsoft's shares have been punished as investors price in a multi-year AI infrastructure build and near-term margin pressure. At $369.91, the stock trades at a materially lower multiple than its 2025 peak and offers cash-flow durability, a fortress balance sheet and exposure to cloud/AI secular growth. This trade idea lays out a mid-term (45 trad…
Merck KGaA (MKKGY) combines a high-quality life-science tools franchise, steady pharma royalties and specialty materials. At $25.44 the stock trades at a reasonable P/E of 18.3 and a market cap of roughly $55.3B, offering a compelling risk/reward for a long trade targeting the $31 52-week high. Technicals show constructive momentum (EMA cross, MACD…
Seagate's HAMR rollout has moved beyond proof-of-concept into a multi-year supply story. With hyperscaler bookings, expanding margins, and visible orders into 2027-2028, the setup favors a tactical long. This trade presents a clear entry, stop and target with mid-term horizon (45 trading days) and defined risks tied to demand cycles, competition an…
Symrise has shown clear operational improvement after a difficult cycle for flavors & fragrances, yet the growth runway is not fully visible. For traders, a disciplined buy-on-weakness with a tight stop and a modest target fits the current risk/reward: the company can rerate if revenue momentum re-accelerates, but that outcome is not guaranteed.
